Decoy Therapeutics Inc.
@decoytx.com
At Decoy, we are pioneering a new category of antiviral medicine. Designable Multi-Antivirals (D-MAVs) are engineered to target shared viral mechanisms, enabling a single, adaptable drug to work across multiple viruses. Not one drug for one virus. One platform for many. Built on our proprietary IMP³ACT platform, which integrates rapid peptide synthesis with AI-enabled design, D-MAVs are designed to move faster into the clinic, learn across programs, and reach the people who need them. Viral disease doesn't just make you sick. It disrupts everything around you. We're building with that reality in mind. [decoytx.com]
Decoy Therapeutics Inc.'s Company Logos
Decoy Therapeutics Inc.'s Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#3C7F83
Ming
60, 127, 131
183, 37, 37
54, 3, 0, 49
#FFCB70
Goldenrod
255, 203, 112
38, 100, 72
0, 20, 56, 0
#32373C
Outer Space
50, 55, 60
210, 9, 22
17, 8, 0, 76
About Decoy Therapeutics Inc.
Decoy Therapeutics Inc. With a mission to protect against both current and future viruses, Decoy Therapeutics takes a unique approach to combatting viral threats. Recognizing that vaccines alone cannot control a pandemic and behavioral defenses are not a long-term solution, Decoy Therapeutics aims to engineer the next generation of antiviral medicines.
By leveraging their scientific expertise, Decoy Therapeutics doesn't simply discover drugs, but rather engineers them to specifically target evolving viruses. They understand that antivirals must aim for where viruses will be, not just where they are currently. With a commitment to equitable global access, Decoy Therapeutics aims to ensure that no one is left behind by current approaches.
Based in Cambridge, MA and New York, NY, Decoy Therapeutics is at the forefront of antiviral research, providing global defense against viral threats. Trust Decoy Therapeutics to protect you against current and future viruses
Company type
Privately Held
Year founded
2020
Company size
2-10 employees
